| Institution: | 1. Clinical Pharmacology and Pharmacotherapy, University of Leuven, Herestraat 49 Box 521, 3000 Leuven, Belgium;2. Erasmus School of Health Policy & Management (ESHPM) and Erasmus Choice Modelling Centre (ECMC), Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands;3. Belgian Health Care Knowledge Centre (KCE), Kruidtuinlaan 55, 1000 Brussels, Belgium;4. Sanofi, 55 Corporate Drive, Bridgewater, NJ 08807, USA;5. Janssen Research & Development, 1125 Trenton-Harbourton Road, P.O. Box 200, Titusville, NJ 08560, USA;6. Quantitative Scientific Consulting, Europabadstr. 8, 35041 Marburg, Germany;1. Erasmus School of Health Policy & Management, Erasmus University Rotterdam, P.O. Box 1738, Rotterdam, 3000 DR the Netherlands;2. Janssen Research & Development, 1125 Trenton-Harbourton Road, PO Box 200, Titusville, NJ, 08560, USA;3. Merck, Sharpe & Dome, 2000 Galloping Hill Rd., Kenilworth, NJ, 07033, USA;4. Department of Business Economics, Erasmus University Rotterdam, P.O. Box 1738, Rotterdam, 3000 DR the Netherlands;5. Clinical Pharmacology and Pharmacotherapy, University of Leuven, Herestraat 49 Box 521, Leuven, 3000 Belgium;6. Sanofi, 55 Corporate Drive Bridgewater, NJ, 08807, USA;7. Erasmus Choice Modelling Centre, Erasmus University Rotterdam, P.O. Box 1738, Rotterdam, 3000 DR the Netherlands;8. Department of Public Health, Erasmus MC – University Medical Centre, Dr. Molewaterplein 40, 3000 CA Rotterdam;1. Kielo Research, Zug, Switzerland;2. Erasmus School of Health Policy and Management & Erasmus Choice Modelling Center, Rotterdam, The Netherlands;3. Manchester Centre for Health Economics, School of Health Sciences, The University of Manchester, Manchester, England, UK;4. Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA;5. Global R&D Epidemiology, Janssen R&D, Titusville, NJ, USA;6. Decision Support and Analysis Staff, Office of Program and Strategic Analysis, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA;7. Evidera, London, England, UK;8. School of Health and Related Research, University of Sheffield, Sheffield, England, UK;9. European Medicines Agency, Amsterdam, The Netherlands;10. Patient Council of the Michael J. Fox Foundation for Parkinson’s Research, New York, NY, USA;11. Google, San Francisco, CA, USA |
